SOLENO THERAPEUTICS INC earnings per share and revenue

6XC earnings per share for the last quarter are -1.64 EUR whereas the estimation was -0.54 EUR which accounts for -202.48% surprise. Company revenue for the same period amounts to 0.00 EUR despite the estimated figure of 0.00 EUR. Estimated earnings per share for the next quarter are -0.99 EUR, and revenue is expected to reach 0.00 EUR. Also watch annual changes over time to get a bigger picture of 6XC earnings per share and revenue dynamics.